Showing 231-240 of 612 results for "".
Treatment Options for Cranial Neuralgias
https://practicalneurology.com/diseases-diagnoses/headache-pain/treatment-options-for-cranial-neuralgias/30465/A review of treatment and coding options for various cranial neuralgias.Continual Growth?
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/PN0809_01-php/30893/As continuous EEG evolves and becomes more efficient, it could improve patient care and present opportunities for specialized neurologists.News
https://practicalneurology.com/columns/practice-management/news/30633/News
https://practicalneurology.com/columns/practice-management/news/30585/Bruxism in the Neurology Clinic
https://practicalneurology.com/diseases-diagnoses/movement-disorders/bruxism-in-the-neurology-clinic/30531/Though rarely a primary presentation in the general neurology practice, teeth grinding, gritting, or clinching may present as a trigger for other neurologic complaints.Parkinson's Pathology: Elucidating the Role of LRRK2
https://practicalneurology.com/diseases-diagnoses/movement-disorders/parkinsons-pathology-elucidating-the-role-of-lrrk2/30475/Playing a critical role in Parkinson's disease, LRRK2 offers a potential path toward better understanding and potentially treating the condition.Mild Cognitive Impairment – Neuropsychological and Behavioral Presentation
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/mild-cognitive-impairment--neuropsychological-and-behavioral-presentation/30529/Alpha-Synuclein: A Therapeutic Target and Potential Biomarker in Parkinson's Disease
https://practicalneurology.com/diseases-diagnoses/movement-disorders/alpha-synuclein-a-therapeutic-target-and-potential-biomarker-in-parkinsons-disease/30407/News
https://practicalneurology.com/columns/practice-management/news/30641/Recent Advances in the Medical Treatment of Epilepsy
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/recent-advances-in-the-medical-treatment-of-epilepsy/30795/From agents in early clinical trials to relatively recent approvals, multiple treatments may improve the care of common and rare forms of epilepsy.